十一月 2025
- Home
- HPRA
十一月 2025的HPRA市场份额分析
"The HPRA regulates medicines and devices for the benefit of people and animals. We are committed to excellence in health product regulation through science, collaboration and innovation. Our remit and regulatory functions include human and veterinary medicines, clinical trials, medical devices, controlled drugs, blood and blood components, tissues and cells, and cosmetic products."
HPRA(包含公司地区分支机构)
查看更多网站流量和参与度信息- hpra.ie
HPRA收入截至 十一月 2025为 50M - 75M
HPRA主要域名产生的收入
3 年中HPRA主要域名的收入
HPRA主要域名的收入
HPRA热门域名的总访问量
了解HPRA市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
HPRA热门域名的平均访问时长
分析HPRA参与度指标。
过去 3 个月的平均访问时长
子公司明细
HPRA热门域名的平均页面浏览量
了解HPRA如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
HPRA 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Health Products Regulatory Authority hired David Muphy as Director of Veterinary Sciences on Aug 9th '25.The HPRA today announced that Dr David Muphy has been appointed Director of Veterinary Sciences.
八月 9, 2025阅读更多
新闻Gabriel Beechinor retired from Health Products Regulatory Authority as Director of Veterinary Sciences on Feb 27th '25.The HPRA today announced the retirement of Dr Gabriel Beechinor, Director of Veterinary Sciences, after more than 37 years of dedicated service to the organisation.
二月 27, 2025阅读更多
新闻Health Products Regulatory Authority sells assets to WuXi Biologics Group.WuXi Biologics announced significant achievements at its Dundalk, Ireland facility, including successful completion of multiple 16,000-liter Process Performance Qualification (PPQ) runs and GMP approvals from HPRA for all three manufacturing facilities.
十二月 5, 2024阅读更多
查看 HPRA 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。